When I took antibiotics for a sinus infection, I began feeling weak and feverish, with diarrhea. I went to the ER and learned I had Clostridioides difficile, an infection in the large intestine. The ...
The FDA on Monday granted approval to CutisPharma's drug Firvanq to treat Clostridium difficile-associated diarrhea and Staphylococcus aureus-associated intestinal inflammation (enterocolitis). Here ...
The ongoing epidemic of severe C. diff diarrheal disease -- driven by a 20-fold more toxic mutant strain of the bacteria -- is fast getting worse. Spread by spores that can live for months on dry ...
Clostridium difficile is the most common cause of nosocomial diarrhea in acute-care settings. Until now, the two available therapies for C. difficile-associated diarrhea (CDAD), vancomycin and ...
Clostridium difficile, a bacterium that causes swelling of the colon and potentially deadly bouts of diarrhea, infects almost half a million people each year and contributes to the deaths of 29,000, ...
Forbes contributors publish independent expert analyses and insights. Keep in mind that this was a very small trial in Norway. Scientists write research letters to medical journals when they don't ...
C. diff is a horrible disease that can cause significant morbidity. It can and often does recur and kills around 30,000 Americans every year. We have made progress in prevention and treatment, but ...
LAS VEGAS — Potentially deadly antibiotic-associated Clostridium difficile-associated diarrhea (CDAD) affects 3 million Americans each year and is increasingly difficult to treat. Clinicians may want ...
Fidaxomicin Ups Outcome of C. difficile-Tied Diarrhea in Cancer For patients with cancer with Clostridium difficile-associated diarrhea, fidaxomicin treatment is associated with improved outcomes ...
Some doctors recommend taking probiotics during and after you complete a course of antibiotics — here's why.
Probiotics -- those products that promise to replenish your gut’s “healthy” microbes -- do seem to help prevent dangerous diarrhea, researchers reported on Thursday. A review of the strongest ...
The FDA on Monday granted approval to CutisPharma’s drug Firvanq to treat Clostridium difficile-associated diarrhea and Staphylococcus aureus-associated intestinal inflammation (enterocolitis). Here ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results